UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States

JAMA dermatology (Chicago, Ill.), 2022-01, Vol.158 (1), p.73

2022

Volltextzugriff (PDF)

Onychodystrophy and tumor-stage mycosis fungoides confined to a single digit: Report of a case and review of nail findings in cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology, 2008-07, Vol.59 (1), p.154-157

2008

Volltextzugriff (PDF)

Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States

JAMA dermatology (Chicago, Ill.), 2022-01, Vol.158 (1), p.68

2022

Volltextzugriff (PDF)

Development and use of alefacept to treat psoriasis

Journal of the American Academy of Dermatology, 2003-08, Vol.49 (2), p.87-97

2003

Volltextzugriff (PDF)

Androgen receptor expression patterns in Becker's nevi: An immunohistochemical study

Journal of the American Academy of Dermatology, 2008-11, Vol.59 (5), p.834-838

2008

Volltextzugriff (PDF)

Impact of obesity and smoking on psoriasis presentation and management

Archives of dermatology (1960), 2005-12, Vol.141 (12), p.1527

2005

Volltextzugriff (PDF)

Efficacy of acitretin and commercial tanning bed therapy for psoriasis

Archives of dermatology (1960), 2003-04, Vol.139 (4), p.436

2003

Volltextzugriff (PDF)

Development and use of alefacept to treat psoriasis: Psoriasis for the clinician: A new therapeutics era (the Biologics) beckons

Journal of the American Academy of Dermatology, 2003, Vol.49 (2), p.S87-S97

2003

Volltextzugriff (PDF)

Reply

Journal of the American Academy of Dermatology, 2002-12, Vol.47 (6), p.972-972, Article a125066

2002

Volltextzugriff (PDF)

Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease

Journal of the American Academy of Dermatology, 2002-12, Vol.47 (6), p.970-972, Article a125067

2002

Volltextzugriff (PDF)

Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis: e1000606

PLoS genetics, 2009-08, Vol.5 (8)

2009

Volltextzugriff (PDF)

Skin and Psoriasis

Atlas of Psoriatic Arthritis, p.53-61

Volltextzugriff (PDF)

Treatment of Psoriasis

Atlas of Psoriatic Arthritis, p.99-113

Volltextzugriff (PDF)

Systemic lupus erythematosus with membranous glomerulonephritis and transverse myelitis associated with anabolic steroid use

Arthritis and rheumatism, 1997-10, Vol.40 (10), p.1899-1902

1997

Volltextzugriff (PDF)

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

The New England journal of medicine, 2015-10, Vol.373 (14), p.1318-1328

2015

Volltextzugriff (PDF)

Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry

Journal of the American Academy of Dermatology, 2024-01, Vol.90 (1), p.82-90

2024

Volltextzugriff (PDF)

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)

Journal of investigative dermatology, 2020-09, Vol.140 (9), p.1784-1793.e2

2020

Volltextzugriff (PDF)

Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients

Nature communications, 2018-10, Vol.9 (1), p.4178-10, Article 4178

2018

Volltextzugriff (PDF)

51447 Long Term Real-World Achievement of Skin Clearance Treatment Targets and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis: 2-year Results from the CorEvitas Psoriasis Registry

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB59-AB59

2024

Volltextzugriff (PDF)

43364 Long Term Real-World Patient-Reported Outcomes with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB189-AB189

2023

Volltextzugriff (PDF)

44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB62-AB62

2023

Volltextzugriff (PDF)

Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry

Dermatology and therapy, 2023-02, Vol.13 (2), p.487-504

2023

Volltextzugriff (PDF)

Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial

Circulation. Cardiovascular imaging, 2018-06, Vol.11 (6), p.e007394-e007394

2018

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

ThemaPsoriasis - Genetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)
Buchkapitel
(2)

Sprache

Englisch
(35)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States

Onychodystrophy and tumor-stage mycosis fungoides confined to a single digit: Report of a case and review of nail findings in cutaneous T-cell lymphoma

Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States

Development and use of alefacept to treat psoriasis

Androgen receptor expression patterns in Becker's nevi: An immunohistochemical study

Impact of obesity and smoking on psoriasis presentation and management

Efficacy of acitretin and commercial tanning bed therapy for psoriasis

Development and use of alefacept to treat psoriasis: Psoriasis for the clinician: A new therapeutics era (the Biologics) beckons

Reply

Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease

Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis: e1000606

Skin and Psoriasis

Treatment of Psoriasis

Systemic lupus erythematosus with membranous glomerulonephritis and transverse myelitis associated with anabolic steroid use

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)

Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways

Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients

51447 Long Term Real-World Achievement of Skin Clearance Treatment Targets and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis: 2-year Results from the CorEvitas Psoriasis Registry

43364 Long Term Real-World Patient-Reported Outcomes with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry

44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry

Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry

The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial

Aktive Filter

Suchergebnisse filtern